Dr Ing hc F Porsche AG banner

Dr Ing hc F Porsche AG
XMUN:P911

Watchlist Manager
Dr Ing hc F Porsche AG Logo
Dr Ing hc F Porsche AG
XMUN:P911
Watchlist
Price: 43.49 EUR -1.67%
Market Cap: €19.8B

Wall St Price Targets

P911 Price Targets Summary
Dr Ing hc F Porsche AG

Wall Street analysts forecast P911 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for P911 is 44.8 EUR with a low forecast of 31.52 EUR and a high forecast of 63.43 EUR.

Lowest Forecast
Price Target
31.52 EUR
28% Downside
Average Forecast
Price Target
44.8 EUR
3% Upside
Highest Forecast
Price Target
63.43 EUR
46% Upside
Dr Ing hc F Porsche AG Competitors:
Price Targets
SPRINT
Sprint Bioscience AB
34% Upside
NOKIA
Nokia Oyj
4% Upside

Revenue
Forecast

4% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
4% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 6 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 8 years is 5%.

Gross Profit
Forecast

-3% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
-3% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 6 years, the compound annual growth rate for Gross Profit has been -3%. The projected CAGR for the next 8 years is 16%.

Operating Income
Forecast

-18% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat
-18% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat

Over the last 6 years, the compound annual growth rate for Operating Income has been -18%. The projected CAGR for the next 8 years is 22%.

Pre-Tax Income
Forecast

-31% / Year
Past Growth
106% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
-31% / Year
Past Growth
106% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been -31%. The projected CAGR for the next 3 years is 106%.

Net Income
Forecast

-27% / Year
Past Growth
34% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
-27% / Year
Past Growth
34% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 6 years, the compound annual growth rate for Net Income has been -27%. The projected CAGR for the next 8 years is 34%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is P911's stock price target?
Price Target
44.8 EUR

According to Wall Street analysts, the average 1-year price target for P911 is 44.8 EUR with a low forecast of 31.52 EUR and a high forecast of 63.43 EUR.

What is the Revenue forecast for Dr Ing hc F Porsche AG?
Projected CAGR
5%

Over the last 6 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 8 years is 5%.

What is the Gross Profit forecast for Dr Ing hc F Porsche AG?
Projected CAGR
16%

Over the last 6 years, the compound annual growth rate for Gross Profit has been -3%. The projected CAGR for the next 8 years is 16%.

What is the Operating Income forecast for Dr Ing hc F Porsche AG?
Projected CAGR
22%

Over the last 6 years, the compound annual growth rate for Operating Income has been -18%. The projected CAGR for the next 8 years is 22%.

What is the Pre-Tax Income forecast for Dr Ing hc F Porsche AG?
Projected CAGR
106%

Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been -31%. The projected CAGR for the next 3 years is 106%.

What is the Net Income forecast for Dr Ing hc F Porsche AG?
Projected CAGR
34%

Over the last 6 years, the compound annual growth rate for Net Income has been -27%. The projected CAGR for the next 8 years is 34%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett